Hwang ES - Search Results

1

"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.

Rosenberg SM, Gierisch JM, Revette AC, Lowenstein CL, Frank ES, Collyar DE, Lynch T, Thompson AM, Partridge AH, Hwang ES. Rosenberg SM, et al. Among authors: hwang es. Cancer. 2022 Apr 15;128(8):1676-1683. doi: 10.1002/cncr.34126. Epub 2022 Feb 22. Cancer. 2022. PMID: 35191017 Free PMC article.

2

Management of ductal carcinoma in situ.

Hwang ES, Esserman LJ. Hwang ES, et al. Surg Clin North Am. 1999 Oct;79(5):1007-30, viii. doi: 10.1016/s0039-6109(05)70058-x. Surg Clin North Am. 1999. PMID: 10572548 Review.

3

Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.

Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM, Waldman FM. Korkola JE, et al. Among authors: hwang es. Cancer Res. 2003 Nov 1;63(21):7167-75. Cancer Res. 2003. PMID: 14612510

4

Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer.

Nyante SJ, Devries S, Chen YY, Hwang ES. Nyante SJ, et al. Among authors: hwang es. Hum Pathol. 2004 Jun;35(6):759-63. doi: 10.1016/j.humpath.2003.11.009. Hum Pathol. 2004. PMID: 15188144

5

Patterns of chromosomal alterations in breast ductal carcinoma in situ.

Hwang ES, DeVries S, Chew KL, Moore DH 2nd, Kerlikowske K, Thor A, Ljung BM, Waldman FM. Hwang ES, et al. Clin Cancer Res. 2004 Aug 1;10(15):5160-7. doi: 10.1158/1078-0432.CCR-04-0165. Clin Cancer Res. 2004. PMID: 15297420

6

Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.

Hwang ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K; National Cancer Institute Breast Cancer Surveillance Consortium. Hwang ES, et al. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2587-93. doi: 10.1158/1055-9965.EPI-07-0458. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18086762

7

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.

Chen YY, DeVries S, Anderson J, Lessing J, Swain R, Chin K, Shim V, Esserman LJ, Waldman FM, Hwang ES. Chen YY, et al. Among authors: hwang es. BMC Cancer. 2009 Aug 18;9:285. doi: 10.1186/1471-2407-9-285. BMC Cancer. 2009. PMID: 19689789 Free PMC article. Clinical Trial.

8

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.

Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. Garwood ER, et al. Among authors: hwang es. Breast Cancer Res Treat. 2010 Jan;119(1):137-44. doi: 10.1007/s10549-009-0507-x. Breast Cancer Res Treat. 2010. PMID: 19728082 Free PMC article. Clinical Trial.

9

The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy.

Hwang ES. Hwang ES. J Natl Cancer Inst Monogr. 2010;2010(41):197-9. doi: 10.1093/jncimonographs/lgq032. J Natl Cancer Inst Monogr. 2010. PMID: 20956829 Free PMC article. Review.

10

Characterizing the impact of 25 years of DCIS treatment.

Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Ozanne EM, et al. Among authors: hwang es. Breast Cancer Res Treat. 2011 Aug;129(1):165-73. doi: 10.1007/s10549-011-1430-5. Epub 2011 Mar 9. Breast Cancer Res Treat. 2011. PMID: 21390494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

706 results

Search Page